| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-08 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-06 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
| mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-06 |